First Human Trials Using Cannabis To Treat Brain Cancer Are Under Way
The picture to your right is showing immunofluorescence of the human glioma cell line. (View more pictures here) A European based pharmaceutical company called GW Pharmaceuticals is set to commence its first phase of clinical trials for the treatment of Glioblastoma Multiforme (GBM). It’s a bio-pharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform. According to the New England Journal of Medicine, GBM accounts for approximately 50% of the 22,500 new cases of brain cancer diagnosed [...]